Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose

被引:174
作者
Lee, Kwang [1 ]
Lee, Chang Yoel [1 ]
Jung, Hyungil [1 ]
机构
[1] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea
基金
新加坡国家研究基金会;
关键词
Controlled drawing lithography; Dissolving microneedle; Transdermal drug delivery; Cutaneous depigmentation; POLYMER MICRONEEDLES; DELIVERY; FABRICATION; SKIN; TRANSPORT; NEEDLES;
D O I
10.1016/j.biomaterials.2011.01.014
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Dissolving microneedles, three-dimensional polymer structures with microscale cross-sectional dimensions, have been introduced as a means of safe transdermal drug delivery. Most dissolving microneedles have been fabricated using a traditional micro-casting method that cures biopolymers within three-dimensional mold, nevertheless, repeated molding process may cause damage to encapsulated drugs, a critical hurdle for clinical application. Here, we describe the stepwise controlled drawing technique that can directly fabricate dissolving microneedle from maltose by precise controlling the drawing time and the viscosity of the maltose. Controlled drawing shaped the particular sharp-conical microneedles of 1200 pm length with tip diameter of 60 pm, and dissolved within 20 min in-vivo after inserting to the skin. This technique surpasses the limitations of micro-casting for dissolving microneedle. Furthermore, transdermal delivery of impermeable hydrophilic molecules such as ascorbic acid-2-glucoside and niacinamide was confirmed as inhibition of cutaneous hypermelanosis. We anticipate that controlled drawing technique will be suitable to design dissolving microneedles for use in minimally invasive transcutaneous drug delivery to patients. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3134 / 3140
页数:7
相关论文
共 30 条
[1]   Micro-scale devices for transdermal drug delivery [J].
Arora, Anubhav ;
Prausnitz, Mark R. ;
Mitragotri, Samir .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (02) :227-236
[2]   Chemical and instrumental approaches to treat hyperpigmentation [J].
Briganti, S ;
Camera, E ;
Picardo, M .
PIGMENT CELL RESEARCH, 2003, 16 (02) :101-110
[3]   Dermal and transdermal drug delivery systems: Current and future prospects [J].
Brown, MB ;
Martin, GP ;
Jones, SA ;
Akomeah, FK .
DRUG DELIVERY, 2006, 13 (03) :175-187
[4]   Transdermal penetration enhancers: Applications, limitations, and potential [J].
Finnin, BC ;
Morgan, TM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (10) :955-958
[5]   Coated microneedles for transdermal delivery [J].
Gill, Harvinder S. ;
Prausnitz, Mark R. .
JOURNAL OF CONTROLLED RELEASE, 2007, 117 (02) :227-237
[6]   The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer [J].
Hakozaki, T ;
Minwalla, L ;
Zhuang, J ;
Chhoa, M ;
Matsubara, A ;
Miyamoto, K ;
Greatens, A ;
Hillebrand, GG ;
Bissett, DL ;
Boissy, RE .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (01) :20-31
[7]   DIFFERENTIAL ANALYSIS OF EXPERIMENTAL HYPERMELANOSIS INDUCED BY UVB, PUVA, AND ALLERGIC CONTACT-DERMATITIS USING A BROWNISH GUINEA-PIG MODEL [J].
IMOKAWA, G ;
KAWAI, M ;
MISHIMA, Y ;
MOTEGI, I .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1986, 278 (05) :352-362
[8]   Feasibility of microneedles for percutaneous absorption of insulin [J].
Ito, Yukako ;
Hagiwara, Eiji ;
Saeki, Atsushi ;
Sugioka, Nobuyuki ;
Takada, Kanji .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 29 (01) :82-88
[9]  
Kim BJ, 2009, BIOCHIP J, V3, P281
[10]  
KIVERIN M D, 1957, Biokhimiia, V22, P617